Northwest Biotherapeutics Inc
OTC:NWBO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Northwest Biotherapeutics Inc (NWBO) under the Base Case is USD per share.
Compared with the current market price of 0.1684 USD, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 2 years.
Create a free account · No card needed
Fundamental Analysis
What Northwest Biotherapeutics Does
Northwest Biotherapeutics is a biotechnology company focused on developing cancer treatments made from a patient’s own immune cells. Its main project is DCVax, a dendritic-cell immunotherapy designed to help the body recognize and attack tumors, especially in brain cancer and other solid tumors.
- Headquarters
- United States of America US
- Employees
- 105
- IPO date
- Dec 14, 2001
Revenue & Expenses Breakdown
Northwest Biotherapeutics Inc
Earnings Waterfall
Northwest Biotherapeutics Inc
What is the Intrinsic Value of one NWBO stock?
The intrinsic value for Northwest Biotherapeutics Inc (NWBO) under the Base Case is USD.
Is NWBO stock undervalued or overvalued?
Compared with the current market price of 0.1684 USD, the stock appears .
